HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Heartflow, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$51.02+2.73 (+5.65%)
Close on Oct 19, 2026
- Market cap
- $4.41B
- P/E (TTM)
- –
- Dividend yield
- –
Heartflow, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $60.31M | $48.99M | $45.50M | $42.95M | $39.99M | $34.30M | $32.07M | $30.17M | $28.41M | 94.1% | +50.8% |
| Rest of World [Member] | $3.77M | $3.60M | – | – | $3.44M | $2.91M | – | – | – | 5.9% | +9.7% |
| Japan | – | – | – | $1.46M | $1.53M | – | – | $1.11M | $1.01M | – | – |
| United Kingdom | – | – | – | $1.52M | $1.56M | – | – | $1.30M | $1.29M | – | – |
| Rest of Europe | – | – | – | $349.00K | $348.00K | – | – | $354.00K | $345.00K | – | – |
From the segment and revenue-disaggregation notes of Heartflow's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.